Boryung Corporation

KSE 003850.KS

Boryung Corporation Market Capitalization on January 14, 2025: USD 597.25 M

Boryung Corporation Market Capitalization is USD 597.25 M on January 14, 2025, a -17.57% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

Boryung Corporation 52-week high Market Capitalization is USD 839.46 M on March 13, 2024, which is 40.55% above the current Market Capitalization.
Boryung Corporation 52-week low Market Capitalization is USD 536.46 M on December 09, 2024, which is -10.18% below the current Market Capitalization.
Boryung Corporation average Market Capitalization for the last 52 weeks is USD 676.69 M.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

KSE: 003850.KS

Boryung Corporation

CEO	Mr. Jay Kim
IPO Date	Jan. 4, 2000
Location	South Korea
Headquarters	136, Changgyeonggung-ro
Employees	1,533
Sector	Health Care
Industries Pharmaceuticals

Description

Boryung Corporation produces and sells pharmaceutical products in South Korea. The company offers cardiovascular products, anticancer products, gastrointestinal products, and API's. It also exports its products to approximately 50 countries on 6 continents, including Japan, China, the Southeast Asia, the Middle East, Europe, South America, and Africa. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is based in Seoul, South Korea.

Key trends

Past 5 years